Accessibility statement

Accessibility statement

This accessibility statement applies to the website The Federal Institute for Drugs and Medical Devices (BfArM) endeavors to make the website accessible in accordance with national legislation implementing Directive (EU) 2016/2102 of the European Parliament and of the Council. The legal basis is the Equality for Persons with Disabilities Act (BGG) and the Ordinance on barrier-free information technology (BITV 2.0) as amended. The vast majority of the requirements of BITV 2.0 in the current version have been implemented. The website is thus largely compatible with the requirements of the BITV. To this end, an internal accessibility audit was conducted. Improvements are in progress. This statement was created on 01.06.2021.

Report barrier! Contact and feedback

If you notice any deficiencies in the accessible design or have any questions on the subject of accessibility, you can contact the press and public relations department by mail, telephone or e-mail:

Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
Presse- und Öffentlichkeitsarbeit
Kurt-Georg-Kiesinger-Allee 3
53175 Bonn
Phone: +49 (0) 228 99 307-3256


If you believe that you have been disadvantaged by an inadequate barrier-free design, you can contact the BGG conciliation body and submit a conciliation request:

Schlichtungsstelle nach dem Behindertengleichstellungsgesetz bei dem Beauftragten der Bundesregierung für die Belange von Menschen mit Behinderungen
Mauerstraße 53
10117 Berlin
Telephone: +49 (0) 30 18 527-2805
Fax: +49 (0) 30 18 527-2901